NVAX

Novavax, Inc.

$10.72

0.03 (0.28%) Today

0.09 (0.85%) After-hours

— up— down

Compare NVAX

Open

$10.63

Previous Close

$10.60

Day Range

$10.34 – $10.79

52-Week Range

$6.20 – $11.97

Volume

3.85M

Exchange

NasdaqGS

About NVAX

Novavax, Inc., based in Gaithersburg, Maryland, develops vaccines to counter infectious diseases. The company developed the Novavax COVID-19 vaccine, now commercialized by Sanofi. The company also develops vaccines for influenza, respiratory syncytial virus (RSV), avian flu, shingles, Clostridioides difficile, and malaria.